Suchergebnisse - "Wang, Chang-Qian"

PubPharm (82)

1

The Impacts of Nirmatrelvir-Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

enthalten in: Cardiovascular drugs and therapy | 2024

von Gu, J. | Han, Z. | Wang, C. | +1

2

The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic

enthalten in: International journal of cardiology. Heart & vasculature | 2024

von Gu, J. | Wang, Y. | Zhang, J. | +1

3

The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention

enthalten in: European journal of internal medicine | 2023

von Gu, J. | Wang, Y. | Wang, C. | +1

4

Roles of oral microbiota and oral-gut microbial transmission in hypertension

enthalten in: Journal of advanced research | 2023

von Chen, B. | Lin, W. | Li, Y. | +21

5

Sacubitril-valsartan in Heart Failure With Preserved Ejection Fraction Following Acute Coronary Syndrome

enthalten in: ResearchSquare.com | 2022

von Han, Z. | Wang, C. | Zhang, J. | +1

6

Extracellular vesicles from hypoxia-preconditioned mesenchymal stem cells alleviates myocardial injury by targeting thioredoxin-interacting protein-mediated hypoxia-inducible factor-1α pathway

enthalten in: World journal of stem cells | 2022

von Mao, C. | Zhang, T. | Li, D. | +5

7

Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fraction

enthalten in: Internal medicine journal | 2022

von Fan, L. | Pan, J. | Lin, H. | +3

8

Initial Invasive or Conservative Strategy in Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease

enthalten in: Frontiers in cardiovascular medicine | 2022

von Gu, J. | Pan, J. | Zhang, J. | +1

9

Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction

enthalten in: Frontiers in cardiovascular medicine | 2022

von Gu, J. | Ke, J. | Wang, Y. | +2

10

Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fraction

enthalten in: Internal Medicine Journal | 2022

von Fan, L. | Pan, J. | Lin, H. | +3

1
2
3
4
5
6
7
8
9
Nächster »
[9]